廣告
香港股市 將收市，收市時間：3 小時 47 分鐘

  • 恒指

    16,469.29
    +217.45 (+1.34%)
     

  • 國指

    5,833.02
    +83.33 (+1.45%)
     

  • 上證綜指

    3,088.33
    +16.94 (+0.55%)
     

  • 滬深300

    3,587.11
    +21.71 (+0.61%)
     

  • 美元

    7.8299
    -0.0002 (-0.00%)
     

  • 人民幣

    0.9236
    -0.0003 (-0.03%)
     

  • 道指

    37,753.31
    -45.66 (-0.12%)
     

  • 標普 500

    5,022.21
    -29.20 (-0.58%)
     

  • 納指

    15,683.37
    -181.88 (-1.15%)
     

  • 日圓

    0.0505
    +0.0000 (+0.04%)
     

  • 歐元

    8.3614
    +0.0053 (+0.06%)
     

  • 英鎊

    9.7620
    +0.0110 (+0.11%)
     

  • 紐約期油

    82.89
    +0.20 (+0.24%)
     

  • 金價

    2,388.30
    -0.10 (-0.00%)
     

  • Bitcoin

    61,875.24
    -1,847.23 (-2.90%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Why Bausch Health Stock Is Tumbling Today

Vandana Singh
·1 分鐘文章

Bausch Health Companies Inc (NYSE: BHC) reported Q1 FY23 revenues of $1.94 billion, up 1% Y/Y, up 4% organic basis, missing the consensus estimate of $1.97 billion.

Revenues for Bausch Health (excl. B+L) was $1.01 billion, down 2%.

Bausch + Lomb segment reported revenues were $931 million, +5%.

Salix segment revenues were $496 million for Q1, compared with $464 million a year ago. Xifaxan, Relistor, and Trulance drove sales growth.

The company reported an EPS loss of $(0.55), compared with $(0.19) a year ago. Adjusted net income attributable to Bausch Health was $191 million, compared with $263 million a year ago, primarily due to higher operating expenses and foreign exchange headwinds.

廣告

View more earnings on BHC

Adjusted EPS came in at $0.52, missing the consensus of $0.72.

Adjusted EBITDA fell to $588 million from $732 million.

Guidance: The company confirmed its FY23 guidance for Bausch Health (excl. B+L) and is providing full-year consolidated sales guidance of $8.35 - $8.55 billion, compared to the consensus of $8.35 billion.

It forecasts FY23 adjusted EBITDA of $3.00 - $3.15 billion.

Price Action: BHC shares are down 18.6% at $6.02 on the last check Thursday.

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

This article Why Bausch Health Stock Is Tumbling Today originally appeared on Benzinga.com

.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.